Indaptus Therapeutics, Inc. (INDP) DCF Valuation

Indaptus Therapeutics, Inc. (INDP) DCF Valuation
  • Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • Professional Design: Trusted, Industry-Standard Templates
  • Pre-Built For Quick And Efficient Use
  • No Expertise Is Needed; Easy To Follow

Indaptus Therapeutics, Inc. (INDP) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Simplify Indaptus Therapeutics, Inc. (INDP) valuation with this customizable DCF Calculator! Featuring real Indaptus financials and adjustable forecast inputs, you can test scenarios and uncover Indaptus fair value in minutes.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019
AY2
2020
AY3
2021
AY4
2022
AY5
2023
FY1
2024
FY2
2025
FY3
2026
FY4
2027
FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -46.1 -3.6 -7.7 -14.9 -16.4 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .9 .0 .0 .0 .0 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -46.9 -3.6 -7.7 -14.9 -16.4 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 10.1 1.6 39.1 26.4 13.4 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 3.5 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .0 .2 2.5 1.4 .8 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -.9 .0 .0 -.2 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -47.6 -3.6 -7.7 -14.3 -16.4 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -51.1 .0 -5.4 -15.6 -16.9 -.8 .0 .0 .0 .0
WACC, % 9.66 9.66 9.66 9.65 9.66 9.66 9.66 9.66 9.66 9.66
PV UFCF
SUM PV UFCF -.7
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -1
Net Debt -13
Equity Value 12
Diluted Shares Outstanding, MM 8
Equity Value Per Share 1.48

What You Will Receive

  • Customizable Excel Template: A fully adaptable Excel-based DCF Calculator featuring pre-filled financial data for Indaptus Therapeutics, Inc. (INDP).
  • Comprehensive Data: Historical performance data and forward-looking projections (as indicated in the highlighted cells).
  • Flexible Forecasting: Modify forecast parameters such as revenue growth, EBITDA %, and WACC.
  • Instant Calculations: Quickly observe how your inputs affect the valuation of Indaptus Therapeutics, Inc. (INDP).
  • Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
  • Intuitive Layout: Organized for clarity and user-friendliness, complete with step-by-step guidance.

Key Features

  • 🔍 Real-Life INDP Financials: Pre-filled historical and projected data for Indaptus Therapeutics, Inc.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Indaptus’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Indaptus’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Indaptus Therapeutics data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Indaptus Therapeutics’ intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose Indaptus Therapeutics, Inc. (INDP) Calculator?

  • User-Friendly Interface: Tailored for both novice users and seasoned professionals.
  • Customizable Inputs: Adjust parameters easily to suit your specific analysis needs.
  • Real-Time Feedback: Observe immediate updates to Indaptus's valuation as you change inputs.
  • Preloaded Data: Comes with Indaptus's latest financial metrics for swift evaluations.
  • Relied Upon by Experts: Favored by investors and analysts for making well-informed choices.

Who Should Use This Product?

  • Biotech Students: Explore drug development processes and apply theoretical knowledge to real-world scenarios.
  • Researchers: Utilize advanced models in their studies related to therapeutic innovations.
  • Investors: Evaluate your investment strategies and analyze valuation metrics for Indaptus Therapeutics, Inc. (INDP).
  • Market Analysts: Enhance your analysis with a customizable model tailored for biotech evaluations.
  • Healthcare Entrepreneurs: Understand how emerging biotech companies like Indaptus Therapeutics, Inc. (INDP) are assessed in the market.

What the Template Contains

  • Pre-Filled Data: Includes Indaptus Therapeutics, Inc.'s historical financials and projections.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze Indaptus Therapeutics, Inc.'s profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.